Edwards J - Search Results

1

SRC family kinase activity is up-regulated in hormone-refractory prostate cancer.

Tatarov O, Mitchell TJ, Seywright M, Leung HY, Brunton VG, Edwards J. Tatarov O, et al. Among authors: edwards j. Clin Cancer Res. 2009 May 15;15(10):3540-9. doi: 10.1158/1078-0432.CCR-08-1857. Epub 2009 May 15. Clin Cancer Res. 2009. PMID: 19447874 Free article.

2

Gene amplifications associated with the development of hormone-resistant prostate cancer.

Edwards J, Krishna NS, Witton CJ, Bartlett JM. Edwards J, et al. Clin Cancer Res. 2003 Nov 1;9(14):5271-81. Clin Cancer Res. 2003. PMID: 14614009

3

The role of c-Jun and c-Fos expression in androgen-independent prostate cancer.

Edwards J, Krishna NS, Mukherjee R, Bartlett JM. Edwards J, et al. J Pathol. 2004 Oct;204(2):153-8. doi: 10.1002/path.1605. J Pathol. 2004. PMID: 15378488

4

Type I receptor tyrosine kinases are associated with hormone escape in prostate cancer.

Bartlett JM, Brawley D, Grigor K, Munro AF, Dunne B, Edwards J. Bartlett JM, et al. Among authors: edwards j. J Pathol. 2005 Mar;205(4):522-9. doi: 10.1002/path.1735. J Pathol. 2005. PMID: 15685688

5

The androgen receptor and signal-transduction pathways in hormone-refractory prostate cancer. Part 1: Modifications to the androgen receptor.

Edwards J, Bartlett JM. Edwards J, et al. BJU Int. 2005 Jun;95(9):1320-6. doi: 10.1111/j.1464-410X.2005.05526.x. BJU Int. 2005. PMID: 15892825 Free article. Review. No abstract available.

6

The androgen receptor and signal-transduction pathways in hormone-refractory prostate cancer. Part 2: Androgen-receptor cofactors and bypass pathways.

Edwards J, Bartlett JM. Edwards J, et al. BJU Int. 2005 Jun;95(9):1327-35. doi: 10.1111/j.1464-410X.2005.05527.x. BJU Int. 2005. PMID: 15892826 Free article. Review. No abstract available.

7

The role of HER1-HER4 and EGFRvIII in hormone-refractory prostate cancer.

Edwards J, Traynor P, Munro AF, Pirret CF, Dunne B, Bartlett JM. Edwards J, et al. Clin Cancer Res. 2006 Jan 1;12(1):123-30. doi: 10.1158/1078-0432.CCR-05-1445. Clin Cancer Res. 2006. PMID: 16397033 Free article.

8

Editorial comment on: Increased expression of tumor-associated trypsin inhibitor, TATI, in prostate cancer and in androgen-independent 22Rv1 cells.

Edwards J, Leung HY. Edwards J, et al. Eur Urol. 2007 Dec;52(6):1680-1. doi: 10.1016/j.eururo.2007.01.098. Eur Urol. 2007. PMID: 17306442 No abstract available.

9

Bad expression influences time to androgen escape in prostate cancer.

Teo K, Gemmell L, Mukherjee R, Traynor P, Edwards J. Teo K, et al. Among authors: edwards j. BJU Int. 2007 Sep;100(3):691-6. doi: 10.1111/j.1464-410X.2007.07001.x. Epub 2007 Jun 2. BJU Int. 2007. PMID: 17542986

10

An increase in N-Ras expression is associated with development of hormone refractory prostate cancer in a subset of patients.

Traynor P, McGlynn LM, Mukhergee R, Grimsley SJ, Bartlett JM, Edwards J. Traynor P, et al. Among authors: edwards j. Dis Markers. 2008;24(3):157-65. doi: 10.1155/2008/918087. Dis Markers. 2008. PMID: 18334737 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,141 results

Search Page

Filters